title: Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents.
abstract: New systemic approaches to the treatment of prostate cancer, biological therapy (including vaccines and antibodies), signal transduction inhibitors and anti-angiogenesis agents were the focus of these ASCO sessions.
authors.affiliation: Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London W1P 6LB, United Kingdom. colinm@cursci.co.uk
authors.forename: C
authors.initials: C
authors.lastname: McKinnon